This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, L J Articles by Mortimer, P P Search for Related Content PubMed PubMed Citation Articles by Anderson, L J Articles by Mortimer, P P

 Previous Article  |  Next Article 

J Clin Microbiol. 1986 October; 24(4): 522-526

Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

ABSTRACT

Acute-phase serum from a patient with aplastic crisis provided sufficient human parvovirus B19 to make a monoclonal antibody against B19 and to develop antigen and immunoglobulin M (IgM) and IgG antibody detection enzyme-linked immunosorbent assays (ELISAs). The indirect capture antibody method was used for all three assays. Antigen was detected in 8 of 29 sera drawn within 2 days of onset of illness from patients with aplastic crisis. These sera had high titers of virus by electron microscopy and DNA hybridization and had no detectable B19 antibody. Antigen was not detected in serum specimens that had low titers of B19 DNA and had B19 antibody. With the IgM ELISA, we detected B19 IgM in over 85% of clinical cases of aplastic crisis and fifth disease and less than 2% of controls. The prevalence of B19 IgG antibodies increased with age. Approximately 2% of children less than 5 years of age and 49% of adults greater than 20 years of age had B19 IgG antibodies. The B19 antibody ELISAs are sensitive and specific tests to detect B19 infections.

This article has been cited by other articles:

• Endo, R., Ishiguro, N., Kikuta, H., Teramoto, S., Shirkoohi, R., Ma, X., Ebihara, T., Ishiko, H., Ariga, T. (2007). Seroepidemiology of Human Bocavirus in Hokkaido Prefecture, Japan. J. Clin. Microbiol. 45: 3218-3223 [Abstract] [Full Text]  
• Waldman, M., Kopp, J. B. (2007). Parvovirus B19 and the Kidney. CJASN 2: S47-S56 [Abstract] [Full Text]  
• Kuo, S.-H., Lin, L.-I., Chang, C.-J., Liu, Y.-R., Lin, K.-S., Cheng, A.-L. (2002). Increased Risk of Parvovirus B19 Infection in Young Adult Cancer Patients Receiving Multiple Courses of Chemotherapy. J. Clin. Microbiol. 40: 3909-3912 [Abstract] [Full Text]  
• Durst, R., Goldschmidt, N., Ben Yehuda, A. (2002). Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa. Rheumatology (Oxford) 41: 1210-1212 [Full Text]  
• Heegaard, E. D., Brown, K. E. (2002). Human Parvovirus B19. Clin. Microbiol. Rev. 15: 485-505 [Abstract] [Full Text]  
• Kerr, J. R (2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59: 672-683 [Full Text]  
• Hokynar, K., Brunstein, J., Söderlund-Venermo, M., Kiviluoto, O., Partio, E. K., Konttinen, Y., Hedman, K. (2000). Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J. Gen. Virol. 81: 1017-1025 [Abstract] [Full Text]  
• Valeur-Jensen, A. K., Pedersen, C. B., Westergaard, T., Jensen, I. P., Lebech, M., Andersen, P. K., Aaby, P., Pedersen, B. N., Melbye, M. (1999). Risk Factors for Parvovirus B19 Infection in Pregnancy. JAMA 281: 1099-1105 [Abstract] [Full Text]  
• Smith, M. A., Shah, N. R., Lobel, J. S., Cera, P. J., Gary, G. W., Anderson, L. J. (1988). Severe Anemia Caused by Human Parvovirus in a Leukemia Patient on Maintenance Chemotherapy. CLIN PEDIATR 27: 383-386 [Abstract]